Tumor Differentiation and EGFR Mutation Associated with Disease-Free Survival in Stage IA Lung Adenocarcinoma Patients with Curative Surgery.
Lu YangChong PangFei XuGuangjian YangHai-Yan XuChang-Li WangYan WangPublished in: Cancer management and research (2020)
This study proposed a new nomogram including tumor differentiation and EGFR mutation to predict recurrence or metastatic probability in stage IA LADC patients who underwent radical surgery. This nomogram could identify patients in the high-risk group and help guide adjuvant treatment in the future.
Keyphrases
- end stage renal disease
- small cell lung cancer
- free survival
- newly diagnosed
- ejection fraction
- minimally invasive
- chronic kidney disease
- peritoneal dialysis
- early stage
- tyrosine kinase
- coronary artery bypass
- lymph node metastasis
- current status
- acute coronary syndrome
- surgical site infection
- rectal cancer
- percutaneous coronary intervention
- combination therapy